Stephen Harbin

Manufactures, wholesales and markets pharmaceutical products

Develops biotechnological products specializing in in-vitro diagnostics and infectious diseases

Supplies capsule manufacturing equipment

Manufactures and distributes hard gelatin capsules and two-piece capsules

Functions as a College/University

Operates as biotechnology company that develops next generation immunotherapy platform to treat cancer

Develops parasitic-ides, vaccines, therapeutics, medicated feed additives and injectable antibiotics

Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics

Albourne Consulting LLC is an independently owned investment advisory and consultancy firm specializing in alternative investments, including private equity, private credit, real assets, real estate, hedge funds, and risk premia. The private company is based in Manchester, NH. The company serves institutional investors such as public and private pension plans, endowments, foundations, financial institutions, family offices, and insurance companies worldwide. Albourne offers services covering the entire investment lifecycle, including sourcing, research, investment due diligence, operational and quantitative due diligence, portfolio construction, risk analysis, continuous monitoring, and implementation support. The firm uses a non-discretionary advisory model and emphasizes transparency, alignment of interests, and industry best practices. Albourne integrates sustainable investing and ESG factors across its services and promotes diversity, equity, and inclusion. Clients access data, analytics, and research through proprietary platforms, and the firm provides educational resources and industry insights through a virtual community.